Metabolic surgery versus conventional therapy in type 2 diabetes
Taken together, addressing an important knowledge gap is changing the attitudes of both patients and diabetologists. [...]during the past 12 years, 12 other randomised controlled trials have shown consistent findings,4 thus providing confidence in the robustness of the data. Dr P Marazzi/Science Pho...
Saved in:
Published in | The Lancet (British edition) Vol. 397; no. 10271; pp. 256 - 257 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
England
Elsevier Ltd
23.01.2021
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Taken together, addressing an important knowledge gap is changing the attitudes of both patients and diabetologists. [...]during the past 12 years, 12 other randomised controlled trials have shown consistent findings,4 thus providing confidence in the robustness of the data. Dr P Marazzi/Science Photo Library The trial by Mingrone and colleagues has several strengths besides the long-term follow-up.1 Patients included had advanced type 2 diabetes, with half of them taking insulin at baseline. [...]detailed information was provided about intensity of lifestyle modification and pharmacotherapy throughout the trial for the medical therapy group. Another limitation was that type 2 diabetes remission was defined as euglycaemia without pharmacotherapy. [...]it was probably impossible for patients in the medical group to ever go into remission considering how advanced their disease was. |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Commentary-1 |
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(21)00129-X |